Originally published July 25 2005
SARS vaccine to have second human trial
by Mike Adams, the Health Ranger, NaturalNews Editor
With the first human trials of a SARS vaccine successfully completed, 300 volunteers will participate in the second phase trials; three successful human trials are needed before the vaccine can be approved for use on the public at large.
A total of 300 volunteers will take part in the second-phase human trials of a SARS (severe acute respiratory syndrome) vaccine, experts said yesterday.
Scientists in Beijing will carry out trials among volunteers aged 20 to 60 to test the effectiveness of the vaccine in human beings, Zhong Nanshan, president of Chinese Medical Association, told the Guangzhou-based Nanfang Metropolis.
According to Yin Hongzhang - an official from the State Drug Administration, which is in charge of supervising trials of any new vaccine or drug - the first phase trials involved 36 volunteers at the Sino-Japanese Friendship Hospital in Beijing on May 22, 2004.
The vaccine was produced by Beijing's Sinovac Biotech Co Ltd in 2004 after SARS emerged in 2003 and again in 2004, leaving at least 350 dead, mostly in China.
Zhong did not release the exact date of the second phase or which hospitals will undertake the trials.
The 300 volunteers will undergo various medical examinations to record the persistence of antibodies over a nine-month period after the vaccine is administered, Zhong said.
The first-phase test was designed to show the vaccine could build antibodies in the volunteers without side effects, but not to see how long antibodies remain present in people's bodies, Zhong added.
"I am fine and have been healthy since I got the vaccine on May 22, 2004," Lan Wanli, a university student based in Beijing, said yesterday.
He was the first person in the world to receive the vaccine.
The second round of tests will involve further experimental verification in other aspects, such as dosage and the schedule for injecting the vaccine to gain a better understanding of how it can be used most effectively, experts said.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml